Shots:
The US FDA has granted FTD to HMI-115 for the treatment of mod. to sev. pain associated with endometriosis
Designation was based on the global P-II dose-finding study assessing HMI-115 vs PBO for 12wks. in 108 females with surgically diagnosed endometriosis across the US, Poland & China, showing significant improvement
Trial showed that HMI-115…
